129 related articles for article (PubMed ID: 37706238)
41. Liposarcomatous differentiation in malignant phyllodes tumours is unassociated with MDM2 or CDK4 amplification.
Lyle PL; Bridge JA; Simpson JF; Cates JM; Sanders ME
Histopathology; 2016 Jun; 68(7):1040-5. PubMed ID: 26542423
[TBL] [Abstract][Full Text] [Related]
42. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
[TBL] [Abstract][Full Text] [Related]
43. [An immobilising malignant phyllodes tumour of the breast].
Fritsche E; Hug U; Winterholer D
Handchir Mikrochir Plast Chir; 2015 Apr; 47(2):142-3. PubMed ID: 25836949
[TBL] [Abstract][Full Text] [Related]
44. The utility of a targeted gene mutation panel in refining the diagnosis of breast phyllodes tumours.
Koh VCY; Ng CCY; Bay BH; Teh BT; Tan PH
Pathology; 2019 Aug; 51(5):531-534. PubMed ID: 31272781
[No Abstract] [Full Text] [Related]
45. Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report.
Sera T; Kashiwagi S; Takashima T; Asano Y; Goto W; Iimori N; Noda S; Onoda N; Ohsawa M; Hirakawa K; Ohira M
BMC Res Notes; 2017 Jan; 10(1):55. PubMed ID: 28103951
[TBL] [Abstract][Full Text] [Related]
46. MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Piscuoglio S; Murray M; Fusco N; Marchiò C; Loo FL; Martelotto LG; Schultheis AM; Akram M; Weigelt B; Brogi E; Reis-Filho JS
Histopathology; 2015 Nov; 67(5):719-29. PubMed ID: 25855048
[TBL] [Abstract][Full Text] [Related]
47. Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: implications for pathogenesis and histogenesis.
Lien HC; Huang CS; Yang YW; Jeng YM
Histopathology; 2016 Feb; 68(3):433-41. PubMed ID: 26109290
[TBL] [Abstract][Full Text] [Related]
48. Malignant phyllodes tumor with heterologous differentiation: A rare case report.
Patil Okaly GV; Devadass CW; Metikurke SH
J Cancer Res Ther; 2015; 11(3):651. PubMed ID: 26458626
[TBL] [Abstract][Full Text] [Related]
49. Immunohistochemical and molecular markers in breast phyllodes tumors.
Korcheva VB; Levine J; Beadling C; Warrick A; Countryman G; Olson NR; Heinrich MC; Corless CL; Troxell ML
Appl Immunohistochem Mol Morphol; 2011 Mar; 19(2):119-25. PubMed ID: 21030860
[TBL] [Abstract][Full Text] [Related]
50. Fine-needle sampling in malignant phyllodes tumors: clinicopathologic study of 22 cases seen at the Institut Curie.
Vladescu T; Klijanienko J; Caillaud JM; Lagacé R; Vielh P
Diagn Cytopathol; 2004 Aug; 31(2):71-6. PubMed ID: 15282716
[TBL] [Abstract][Full Text] [Related]
51. Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast.
Geyer FC; Burke KA; Piscuoglio S; Ng CKY; Papanastasiou AD; Marchiò C; Selenica P; Edelweiss M; Murray MP; Brogi E; Soslow RA; Rubin BP; Norton L; Reis-Filho JS; Weigelt B
Mol Oncol; 2017 Aug; 11(8):913-926. PubMed ID: 28267263
[TBL] [Abstract][Full Text] [Related]
52. Genomic characterisation of breast fibroepithelial lesions in an international cohort.
Md Nasir ND; Ng CCY; Rajasegaran V; Wong SF; Liu W; Ng GXP; Lee JY; Guan P; Lim JQ; Thike AA; Koh VCY; Loke BN; Chang KTE; Gudi MA; Lian DWQ; Madhukumar P; Tan BKT; Tan VKM; Wong CY; Yong WS; Ho GH; Ong KW; ; Tan P; Teh BT; Tan PH
J Pathol; 2019 Dec; 249(4):447-460. PubMed ID: 31411343
[TBL] [Abstract][Full Text] [Related]
53. Morphologic and genetic heterogeneity in breast fibroepithelial lesions-a comprehensive mapping study.
Tan BY; Md Nasir ND; Chang HY; Ng CCY; Guan P; Nagarajan S; Rajasegaran V; Lee JY; Lim JQ; Thike AA; Teh BT; Tan PH
Mod Pathol; 2020 Sep; 33(9):1732-1745. PubMed ID: 32322022
[TBL] [Abstract][Full Text] [Related]
54. Association of clinicopathological features and prognosis of TERT alterations in phyllodes tumor of breast.
Tsang JYS; Hui YK; Lee MA; Lacambra M; Ni YB; Cheung SY; Wu C; Kwong A; Tse GMK
Sci Rep; 2018 Mar; 8(1):3881. PubMed ID: 29497099
[TBL] [Abstract][Full Text] [Related]
55. Cytogenetic findings in phyllodes tumors of the breast: karyotypic complexity differentiates between malignant and benign tumors.
Dietrich CU; Pandis N; Rizou H; Petersson C; Bardi G; Qvist H; Apostolikas N; Bøhler PJ; Andersen JA; Idvall I; Mitelman F; Heim S
Hum Pathol; 1997 Dec; 28(12):1379-82. PubMed ID: 9416694
[TBL] [Abstract][Full Text] [Related]
56. Disseminated malignant phyllodes: Presentation after a decade.
Sherin SB; Joseph LD; Pavithra V; Manickavasagam M
J Cancer Res Ther; 2023; 19(5):1439-1442. PubMed ID: 37787325
[TBL] [Abstract][Full Text] [Related]
57. Progression of Fibroadenoma to Malignant Phyllodes Tumour in a 14-Year Female.
Faridi SH; Siddiqui B; Ahmad SS; Aslam M
J Coll Physicians Surg Pak; 2018 Jan; 28(1):69-71. PubMed ID: 29290198
[TBL] [Abstract][Full Text] [Related]
58. Malignant cystosarcoma phyllodes with lymph node metastasis--a case report.
Harada S; Fujiwara H; Hisatsugu T; Sugihara H
Jpn J Surg; 1987 May; 17(3):174-7. PubMed ID: 3041087
[TBL] [Abstract][Full Text] [Related]
59. Update on the diagnosis and management of malignant phyllodes tumors of the breast.
Strode M; Khoury T; Mangieri C; Takabe K
Breast; 2017 Jun; 33():91-96. PubMed ID: 28327352
[TBL] [Abstract][Full Text] [Related]
60. Relation between DNA ploidy and the clinical behavior of phyllodes tumors.
Layfield LJ; Hart J; Neuwirth H; Bohman R; Trumbull WE; Giuliano AE
Cancer; 1989 Oct; 64(7):1486-9. PubMed ID: 2550124
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
